Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Gentamicin Treatment of Patients With Muscular Dystrophy Due to Nonsense Mutations in Dystrophin

NCT00005574 is registered in ClinicalTrials.gov with National Institute of Neurological Disorders and Stroke (NINDS) as lead sponsor.

NCT NCT00005574
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00005574 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Gentamicin Treatment of Patients With Muscular Dystrophy Due to Nonsense Mutations in Dystrophin
Lead sponsor
National Institute of Neurological Disorders and Stroke (NINDS)
Phase
Phase 1
Overall status
Completed
Start date
February 29, 2000
Completion date
January 31, 2001
Enrollment
4
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

becker muscular dystrophy, duchenne muscular dystrophy